Joint Scientific Consultations (Art. 16–21): A Joint Scientific Consultation (JSC) aims to advice the Health Technology Developer on evidence likely to be required in a subsequent Joint Clinical Assessment of a health technology.
Health technologies eligible for joint scientific consultations are those for which a joint clinical assessment hasn't been planned but are likely candidates. These consultations occur at the request of the developer.